article thumbnail

Changes in patterns and referrals of Nova Scotians seeking mental health care through 2-1-1 Referral Service [Health care services, delivery, and financing]

Annals of Family Medicine

Context 2-1-1 is a designated phone help line in Canada and the US that provides referrals for individuals to local government and community-based services for a wide variety of needs, including social, health care, and mental health services. 2-1-1 Nova Scotia has operated since 2013 as a nonprofit that offers 24/7 assistance.

Referral 130
article thumbnail

Biden Administration Facing Renewed Pressure to Legalize Cannabis

FDA Law Blog

Cole providing guidance to U.S. Attorneys in August 2013 advising that DOJ would not take enforcement action against marijuana-related businesses operating in compliance with state law unless the businesses implicated one of eight specified enforcement priorities. 3 (July 5, 2022) [hereinafter CRCC Letter].

Medical 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Embracing Life's Full Circle Moments

Aspiring Minority Doctor

If you've been following my blog since it's inception in 2013, then you already know how much of an inspiration Dr. Barbara Ross-Lee is to me. Hopefully one day I can give back and serve as an inspiration to someone just like many individuals such as Dr. Barbara Ross-Lee who provided inspiration and encouragement for me :)

article thumbnail

Rheumatology Board Meeting Summary | Spring 2025

ABIM

Dave, MD, MPH , inquired how stressors may contribute to candidates failing the certification examination and Dr. McDonald stated that knowledge gaps were the primary cause, though ABIM provides safeguards to reduce stress like grace periods and consideration of compassionate exemptions for extraordinary life circumstances.

article thumbnail

Federal Marijuana Rescheduling: States Get Ready

FDA Law Blog

Governors, state cannabis regulators, law enforcement groups and local governments weighed in, as did marijuana advocates and opponents, marijuana industry associations, Members of Congress, federal law enforcement groups, healthcare and human rights groups, unions and trade associations, and private individuals.

article thumbnail

FDA Creates a New Advisory Committee for Genetic Metabolic Diseases – Could This Be an Opportunity to Support Rare Disease Product Development More Broadly?

FDA Law Blog

Dr. Janet Maynard, Director of this Office, highlighted in the press release that “[g]enetic metabolic diseases include very rare diseases that individually affect a limited number of patients. Drug development for these conditions has unique and complex challenges, therefore few treatments are available to patients.”

article thumbnail

Through with Breakthrough? FDA’s New Draft Guidance Reflects an Uptick in Notices of Intent to Rescind

FDA Law Blog

The Expedited Programs Guidance describes situations warranting rescission as when emerging data no longer support the BTD, another product gains traditional approval and evidence is not provided that the designated drug may demonstrate substantial approval over the approved product, or when the program is no longer being pursued.

IT 52